SINEDORE
Live / Applied — First extension granted (statement of use) (as of 12 Nov 2025)
What this means for you
Not registered yet, but its 03 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98632503
- Mark type
- Design + words
- Filed
- 03 Jul 2024
- Published for opposition
- 15 Apr 2025
- Attorney of record
- J. Damon Ashcraft
Goods and services
- Class 042 — Scientific and technological services: Providing pharmaceutical and biomedical research and development; research and development of new products for others; technological research in the field of diagnostic, therapeutic, and pharmaceutical applications of medical reagents; scientific research; chemical research; Scientific and technological services, namely, scientific research and analysis in the field of medical reagents for diagnostic, therapeutic, and pharmaceutical applications, including development, testing, and validation; Pharmaceutical development
Owner
- Sinedore Medicine Inc., Taipei, TW
- Sinedore Medicine Inc., Taipei, TW
Prosecution history
- 13 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 12 Nov 2025 — SOU EXTENSION 1 GRANTED
- 12 Nov 2025 — SOU EXTENSION 1 FILED
- 12 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
- 19 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 19 Mar 2025 — EXAMINERS AMENDMENT E-MAILED
- 19 Mar 2025 — EXAMINERS AMENDMENT -WRITTEN
- 04 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED